Categories: Uncategorized

Serum & Bharat Biotech can do intranasal vaccine trials in India after approval Says Dr. Harsh Vardhan

Bharat Biotech and Serum India may pursue clinical trials in India of intranasal vaccine on Covid-19 after receiving approval from the regulatory authority in the coming months. During Sunday Samvaad-16 Union Health Minister Dr. Harsh Vardhan said “There are no intranasal COVID-19 vaccines in India at the moment, Serum India and Bharat Biotech are expected to pursue clinical trials of such vaccines in India in the coming months on receipt of regulatory approval.

Medically Speaking Team

Recent Posts

India’s Cancer Care Revolution: What to Expect by 2025

In recent years, India has made significant strides in the fight against cancer, with an…

4 hours ago

Boost Brain Health with the MIND Diet: A Powerful Tool Against Cognitive Decline

As we age, our cognitive abilities naturally decline, but diet has emerged as a key…

4 hours ago

AI in Healthcare: Revolutionizing Personalised Medicine in Andhra Pradesh

In a significant move toward revolutionizing patient care, a panel discussion on Artificial Intelligence (AI)-based…

4 hours ago

AI Revolutionizes Breast Cancer Detection with 17% Accuracy Boost

Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. Early…

4 hours ago

Living Near Airports: Is Your Heart at Risk?

Airport Proximity: Can living near an airport increase your risk of a heart attack? A…

4 hours ago

The Silent Epidemic: Superbugs Push Indian Families into Debt

Antimicrobial resistance (AMR), the ability of bacteria, fungi, and parasites to resist the effects of…

1 day ago